wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49097109-07C421A6-28B6-4AE9-ABFB-55AB0915F2A0
Q49097109-07C421A6-28B6-4AE9-ABFB-55AB0915F2A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49097109-07C421A6-28B6-4AE9-ABFB-55AB0915F2A0
Neither creatinine nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents.
P2860
Q49097109-07C421A6-28B6-4AE9-ABFB-55AB0915F2A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49097109-07C421A6-28B6-4AE9-ABFB-55AB0915F2A0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae5620d12df11fcf479d9e71bb726bc6cbea6e77
P2860
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.